Scientific Progress and the Bayh-Dole Act: Exploring the role and significance of a landmark law

Location: 
American Association for the Advancement of Science
Address: 
1200 New York Avenue, NW
Washington, DC 20005
United States
Event Date: 
Thursday, June 13, 2019
9:30 a.m. - 11:30 a.m.

By addressing gaps in the intellectual property framework surrounding federally funded research and helping to foster a robust ecosystem for public-private partnership, the 1980 Bayh-Dole Act has played a pivotal role in fueling scientific and technological progress,  conveying the benefits of federally funded research to the public, and – in an ever-changing fiscal and economic climate – assuring sustained public and policymaker support for federal research funding. As the 40th anniversary of this landmark law approaches, this interactive panel discussion will touch on the history and impact of Bayh-Dole and explore the implications for science policy going forward.

NETWORKING COFFEE: 9:30 a.m.
PANEL DISCUSSION: 10 - 10:50 a.m.
AUDIENCE Q&A: 10:50 -11:30 a.m.

Join the conversation on Twitter using #BayhDole and #techtransfer; @ResearchAmerica

Panelists

Joseph Allen
Founder, Allen and Associates

Marc Boutin, JD
Chief Executive Officer, National Health Council (NHC)

Jessica Sebeok, JD
Deputy Vice President for Federal Relations and Counsel for Policy,
Association of American Universities (AAU)

Ken Porter
Director, UM Ventures - CP (UMV-CP)

Stephen Heinig
Director, Science Policy, Association of American Medical Colleges
(AAMC)

MODERATOR: Ellie Dehoney, Vice President, Policy and Advocacy, Research!America

Media Contacts

Robert Shalett
Director of Communications 
571-482-2737

Without continued support for health research, many of the most promising young scientists, their ideas and a myriad of potentially life-changing scientific breakthroughs will vanish into oblivion.
Paul Marinec, PhD; University of California San Francisco